The Australian Rare Cancer (ARC) Portal is an online platform and clinical referral service providing a national approach to rare cancer care and research.
By referring your patient with a rare cancer (including patients with an uncommon or rare molecular variant of a common cancer), the ARC Portal acts a single point of contact to assist treating clinicians in:
- Facilitating clinical advice from our network of national and international tumour stream experts
- Identify research opportunities or clinical trial options
- Advise on molecular or germline testing or assist in the interpretation of existing molecular reports
The ARC Portal also serves as a national platform to collate rare cancer clinical data and biospecimen sample accrual through its shared infrastructure with the Walter and Eliza Hall Institute of Medical Research (WEHI) Stafford-Fox Rare Cancer Program, a research collaboration focused on understanding the biology of rare cancers.
The ARC Portal is supported by BioGrid Australia with funding via the Australian Genomic Cancer Medicine Centre, now known as Omico. Our team is led by Prof. Clare Scott, Medical Oncologist at Peter MacCallum Cancer Centre and the Walter and Eliza Hall Institute, a leading expert in rare cancer research.